标题
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
作者
关键词
-
出版物
Cancers
Volume 11, Issue 7, Pages 978
出版商
MDPI AG
发表日期
2019-07-12
DOI
10.3390/cancers11070978
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The functional role of integrins during intra- and extravasation within the metastatic cascade
- (2019) Greta Sökeland et al. Molecular Cancer
- Targeting Alterations in the RAF–MEK Pathway
- (2019) Rona Yaeger et al. Cancer Discovery
- Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
- (2019) Jonathan Cooper et al. CANCER CELL
- Integrin Regulation of CAF Differentiation and Function
- (2019) C. Michael DiPersio et al. Cancers
- Integrins, CAFs and Mechanical Forces in the Progression of Cancer
- (2019) Imjoo Jang et al. Cancers
- Targeting the integrin interactome in human disease
- (2018) Miguel Vicente-Manzanares et al. CURRENT OPINION IN CELL BIOLOGY
- Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases
- (2018) Mario E.G. Moral et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Extracellular matrix internalization links nutrient signalling to invasive migration
- (2018) Elena Rainero INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Targeted thermal therapy with genetically engineered magnetite magnetosomes@RGD: Photothermia is far more efficient than magnetic hyperthermia
- (2018) Anouchka Plan Sangnier et al. JOURNAL OF CONTROLLED RELEASE
- RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy
- (2018) Shuang Fu et al. JOURNAL OF DRUG TARGETING
- cRGD functionalised nanocarriers for targeted delivery of bioactives
- (2018) K. R. Gajbhiye et al. JOURNAL OF DRUG TARGETING
- Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors
- (2018) Wagner Ricardo Montor et al. Molecular Cancer
- Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands
- (2018) P. M. Peiris et al. Nanoscale
- What about α v β 3 integrins in molecular imaging in oncology?
- (2018) Frederic Debordeaux et al. NUCLEAR MEDICINE AND BIOLOGY
- PKB/Akt-dependent regulation of inflammation in cancer
- (2018) Fengyuan Tang et al. SEMINARS IN CANCER BIOLOGY
- Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
- (2018) Laura Vera-Ramirez et al. Nature Communications
- Fluorescence imaging of invasive head and neck carcinoma cells with integrin αvβ6-targeting RGD-peptides: an approach to a fluorescence-assisted intraoperative cytological assessment of bony resection margins
- (2018) M. Nieberler et al. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
- Dormancy in cancer
- (2018) Hiroko Endo et al. CANCER SCIENCE
- Role of Extracellular Matrix in Development and Cancer Progression
- (2018) Cameron Walker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrin activation by talin, kindlin and mechanical forces
- (2018) Zhiqi Sun et al. NATURE CELL BIOLOGY
- RGD-modified polymer and liposome nanovehicles: Recent research progress for drug delivery in cancer therapeutics
- (2018) Yu Cheng et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
- (2017) Rehman Ata et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Interconnections between Autophagy and Integrin-Mediated Cell Adhesion
- (2017) Ariadne Vlahakis et al. JOURNAL OF MOLECULAR BIOLOGY
- Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
- (2017) ShaghayeghHaghjooy Javanmard et al. Journal of Research in Medical Sciences
- A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties
- (2017) A. M. Clark et al. LAB ON A CHIP
- Integrin-targeted peptide- and peptidomimetic-drug conjugates for the treatment of tumors
- (2017) Daniela Arosio et al. Recent Patents on Anti-Cancer Drug Discovery
- Multiple biological functions of Twist1 in various cancers
- (2017) Zhixiang Zhao et al. Oncotarget
- Exploring the Role of RGD-Recognizing Integrins in Cancer
- (2017) Markus Nieberler et al. Cancers
- Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators
- (2017) Alessandra Tolomelli et al. Cancers
- Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
- (2017) et al. Cancers
- Advancement in integrin facilitated drug delivery
- (2016) Daniela Arosio et al. ADVANCED DRUG DELIVERY REVIEWS
- Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
- (2016) Ann Ager et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- 99mTc-HisoDGR as a Potential SPECT Probe for Orthotopic Glioma Detection via Targeting of Integrin α5β1
- (2016) Haitao Zhao et al. BIOCONJUGATE CHEMISTRY
- The complexity of integrins in cancer and new scopes for therapeutic targeting
- (2016) Hellyeh Hamidi et al. BRITISH JOURNAL OF CANCER
- The role of integrins in TGFβ activation in the tumour stroma
- (2016) Zareen Khan et al. CELL AND TISSUE RESEARCH
- Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2016) M. Hussain et al. CLINICAL CANCER RESEARCH
- Mechanosensitivity of integrin adhesion complexes: role of the consensus adhesome
- (2016) Edward R. Horton et al. EXPERIMENTAL CELL RESEARCH
- Synergistic active targeting of dually integrin α v β 3 /CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies
- (2016) Sanjun Shi et al. JOURNAL OF CONTROLLED RELEASE
- Joint Antiangiogenic Effect of ATN-161 and Anti-VEGF Antibody in a Rat Model of Early Wet Age-Related Macular Degeneration
- (2016) Wen-Qiu Wang et al. MOLECULAR PHARMACEUTICS
- Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse
- (2016) Jiyeon Ryu et al. MOLECULES AND CELLS
- Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review
- (2016) Jiahao Su et al. ONCOLOGY RESEARCH
- Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways
- (2016) Giulia Santinon et al. TRENDS IN CELL BIOLOGY
- Corrigendum: Beta 1-integrin–c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes
- (2016) Rachel Barrow-McGee et al. Nature Communications
- Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma
- (2016) Xiao-Yan Ming et al. Nature Communications
- The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis
- (2016) Yu-Ting Huang et al. Oncotarget
- Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
- (2016) Michael Weller et al. Oncotarget
- Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
- (2016) Haojun Chen et al. Theranostics
- Cell surface receptors for CCN proteins
- (2016) Lester F. Lau Journal of Cell Communication and Signaling
- Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis
- (2015) Elizabeth Doolittle et al. ACS Nano
- Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands
- (2015) Oleg V. Maltsev et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
- (2015) J. Vansteenkiste et al. ANNALS OF ONCOLOGY
- Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer
- (2015) Megan Agajanian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interaction of kindlin-2 with integrin 3 promotes outside-in signaling responses by the V 3 vitronectin receptor
- (2015) Z. Liao et al. BLOOD
- Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial–mesenchymal transition
- (2015) Eun-Hee Nam et al. CARCINOGENESIS
- In vivo biokinetic and metabolic characterization of the 68Ga-labelled α5β1-selective peptidomimetic FR366
- (2015) Calogero D’Alessandria et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
- (2015) Thomas R. Cox et al. NATURE
- Integrin endosomal signalling suppresses anoikis
- (2015) Jonna Alanko et al. NATURE CELL BIOLOGY
- Current status and future directions of anti-angiogenic therapy for gliomas
- (2015) Wolfgang Wick et al. NEURO-ONCOLOGY
- Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
- (2015) L. Burt Nabors et al. NEURO-ONCOLOGY
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- Fibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin αvβ5-mediated adhesion
- (2015) Sarah Knuchel et al. Oncotarget
- Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways
- (2015) Li Yang et al. Oncotarget
- Medical management of lung cancer: Experience in China
- (2015) Yuankai Shi et al. Thoracic Cancer
- Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients withKRASwild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial
- (2014) E. Élez et al. ANNALS OF ONCOLOGY
- Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
- (2014) J. B. Vermorken et al. ANNALS OF ONCOLOGY
- Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
- (2014) Marina Colombo et al. Annual Review of Cell and Developmental Biology
- Disruption of integrin–fibronectin complexes by allosteric but not ligand-mimetic inhibitors
- (2014) A. Paul Mould et al. BIOCHEMICAL JOURNAL
- Redefining the role(s) of endothelial αvβ3-integrin in angiogenesis: Figure 1
- (2014) Samuel J. Atkinson et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system
- (2014) S E Wheeler et al. BRITISH JOURNAL OF CANCER
- Dihydropyrimidine Accumulation Is Required for the Epithelial-Mesenchymal Transition
- (2014) Yoav D. Shaul et al. CELL
- Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland
- (2014) Jay S. Desgrosellier et al. DEVELOPMENTAL CELL
- Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion
- (2014) Ahmed A. Ashour et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- Cilengitide in glioblastoma: when did it fail?
- (2014) Olivier L Chinot LANCET ONCOLOGY
- An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
- (2014) Laetitia Seguin et al. NATURE CELL BIOLOGY
- Regulated Splicing of the α6 Integrin Cytoplasmic Domain Determines the Fate of Breast Cancer Stem Cells
- (2014) Hira Lal Goel et al. Cell Reports
- H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrinα5β1?
- (2014) Roland Haubner et al. Biomed Research International
- Anoikis molecular pathways and its role in cancer progression
- (2013) Paolo Paoli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis
- (2013) Robert S. Kerbel et al. BREAST
- A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal
- (2013) Yanyan Zheng et al. CANCER CELL
- The relevance of the TGF-β Paradox to EMT-MET programs
- (2013) Chevaun D. Morrison et al. CANCER LETTERS
- 1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond
- (2013) A. Jahangiri et al. CANCER RESEARCH
- Stromally Derived Lysyl Oxidase Promotes Metastasis of Transforming Growth Factor- -Deficient Mouse Mammary Carcinomas
- (2013) M. W. Pickup et al. CANCER RESEARCH
- Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin 1/Src/Akt-Driven Bypass Signaling
- (2013) R. Kanda et al. CANCER RESEARCH
- Mechanisms Governing Metastatic Dormancy and Reactivation
- (2013) Filippo G. Giancotti CELL
- Acute Depletion of Endothelial β3-Integrin Transiently Inhibits Tumor Growth and Angiogenesis in Mice
- (2013) Veronica Steri et al. CIRCULATION RESEARCH
- Development of RGD-Based Radiotracers for Tumor Imaging and Therapy: Translating from Bench to Bedside
- (2013) Z. Liu et al. CURRENT MOLECULAR MEDICINE
- GLI1 finds a new role in cancer stem cell biology
- (2013) Martin E. Fernandez-Zapico EMBO Molecular Medicine
- A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy
- (2013) Manfred Wirth et al. EUROPEAN UROLOGY
- Integrin modulators: a patent review
- (2013) Tobias G Kapp et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- CD49f-positive cell population efficiently enriches colon cancer-initiating cells
- (2013) NAOTSUGU HARAGUCHI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells
- (2013) Lara H. El Touny et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Extracellular vesicles: biology and emerging therapeutic opportunities
- (2013) Samir EL Andaloussi et al. NATURE REVIEWS DRUG DISCOVERY
- Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma
- (2013) TRACEY AMANDA MARTIN et al. ONCOLOGY REPORTS
- Validation of stem cell markers in clinical prostate cancer: α6-Integrin is predictive for non-aggressive disease
- (2013) A. Marije Hoogland et al. PROSTATE
- Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase
- (2013) Isabel Serrano et al. Nature Communications
- Integrins and metastasis
- (2013) Kirat Kumar Ganguly et al. Cell Adhesion & Migration
- Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial–mesenchymal transition-like change of breast cancer cells
- (2013) D Katoh et al. Oncogenesis
- Tumor Targeting via Integrin Ligands
- (2013) Udaya Kiran Marelli et al. Frontiers in Oncology
- A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer
- (2012) A. Heidenreich et al. ANNALS OF ONCOLOGY
- Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer
- (2012) B. Besse et al. ANNALS OF ONCOLOGY
- Recombinant human endostatin combined with definitive chemoradiotherapy as primary treatment for patients with unresectable but without systemic metastatic squamous cell carcinoma of the oesophagus
- (2012) Z Zhong et al. BRITISH JOURNAL OF RADIOLOGY
- A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)
- (2012) L. Burt Nabors et al. CANCER
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model
- (2012) Timo L.M. ten Hagen et al. INTERNATIONAL JOURNAL OF CANCER
- Role of monocarboxylate transporters in human cancers: state of the art
- (2012) Céline Pinheiro et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy
- (2012) Iris Eke et al. JOURNAL OF CLINICAL INVESTIGATION
- The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination
- (2012) Lydia M Balz et al. JOURNAL OF PATHOLOGY
- RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
- (2012) Fabienne Danhier et al. MOLECULAR PHARMACEUTICS
- Building the niche: The role of the S100 proteins in metastatic growth
- (2012) Eugene Lukanidin et al. SEMINARS IN CANCER BIOLOGY
- Concepts of metastasis in flux: The stromal progression model
- (2012) Jonathan P. Sleeman et al. SEMINARS IN CANCER BIOLOGY
- New insights into the mechanisms of organ-specific breast cancer metastasis
- (2012) Girieca Lorusso et al. SEMINARS IN CANCER BIOLOGY
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
- (2011) S O'Day et al. BRITISH JOURNAL OF CANCER
- ATM-Mediated DNA Damage Signals Mediate Immune Escape through Integrin- v 3-Dependent Mechanisms
- (2011) M. Jinushi et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- 1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence
- (2011) D. Barkan et al. CLINICAL CANCER RESEARCH
- Volociximab in cancer
- (2011) Salah Almokadem et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
- (2011) Katherine M. Bell-McGuinn et al. GYNECOLOGIC ONCOLOGY
- Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma
- (2011) Steven J. O’Day et al. INVESTIGATIONAL NEW DRUGS
- Interstitial guidance of cancer invasion
- (2011) Pavlo G. Gritsenko et al. JOURNAL OF PATHOLOGY
- The Role of Lysyl Oxidase in SRC-Dependent Proliferation and Metastasis of Colorectal Cancer
- (2011) Ann-Marie Baker et al. JNCI-Journal of the National Cancer Institute
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
- (2011) Thordur Oskarsson et al. NATURE MEDICINE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- 68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging
- (2011) F. Buchegger et al. NUKLEARMEDIZIN-NUCLEAR MEDICINE
- CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin–TGFβ signaling
- (2011) P-K Lo et al. ONCOGENE
- HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs
- (2011) H Zhang et al. ONCOGENE
- Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
- (2011) C. C.-L. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
- (2010) Peter Hersey et al. CANCER
- Integrin Alpha 6 Regulates Glioblastoma Stem Cells
- (2010) Justin D. Lathia et al. Cell Stem Cell
- Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
- (2010) Dalit Barkan et al. EUROPEAN JOURNAL OF CANCER
- Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium
- (2010) Ajjai Alva et al. INVESTIGATIONAL NEW DRUGS
- Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
- (2010) Roger Stupp et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacodynamic (Phase 0) Study Using Etaracizumab in Advanced Melanoma
- (2010) Stergios J. Moschos et al. JOURNAL OF IMMUNOTHERAPY
- Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
- (2010) A K Mitra et al. ONCOGENE
- Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
- (2009) Janine T. Erler et al. CANCER CELL
- Cell Adhesion Molecules: Role and Clinical Significance in Cancer
- (2009) Nektaria Makrilia et al. CANCER INVESTIGATION
- Tumor Self-Seeding by Circulating Cancer Cells
- (2009) Mi-Young Kim et al. CELL
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms
- (2009) Samuel Schmidt et al. CELL AND TISSUE RESEARCH
- Integrin α3β1–dependent β-catenin phosphorylation links epithelial Smad signaling to cell contacts
- (2009) Young Kim et al. JOURNAL OF CELL BIOLOGY
- Regulation of 4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition
- (2009) X. Yang et al. JOURNAL OF CELL SCIENCE
- Loss of the Tumor Suppressor Gene NF2, Encoding Merlin, Constitutively Activates Integrin-Dependent mTORC1 Signaling
- (2009) M. A. Lopez-Lago et al. MOLECULAR AND CELLULAR BIOLOGY
- Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
- (2009) Zachary T. Schafer et al. NATURE
- An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
- (2009) Jay S Desgrosellier et al. NATURE MEDICINE
- Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
- (2009) Andrew R Reynolds et al. NATURE MEDICINE
- The Integrin Antagonist Cilengitide Activates αVβ3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells
- (2009) Gian Carlo Alghisi et al. PLoS One
- Interaction of monocarboxylate transporter 4 with β1-integrin and its role in cell migration
- (2008) Shannon M. Gallagher et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Integrins in breast cancer dormancy
- (2008) STEPHANIE M. PONTIER et al. APMIS
- CYR61 and V 5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
- (2008) Y. Monnier et al. CANCER RESEARCH
- Integrin αvβ3-targeted cancer therapy
- (2008) Zhaofei Liu et al. DRUG DEVELOPMENT RESEARCH
- The tumor microenvironment and its contribution to tumor evolution toward metastasis
- (2008) Girieca Lorusso et al. HISTOCHEMISTRY AND CELL BIOLOGY
- The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells
- (2008) Zhen Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
- (2008) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Cell-Derived Clusterin Modulates the Phosphatidylinositol 3'-Kinase-Akt Pathway through Attenuation of Insulin-Like Growth Factor 1 during Serum Deprivation
- (2008) H. Jo et al. MOLECULAR AND CELLULAR BIOLOGY
- β1 Integrin deletion from the basal compartment of the mammary epithelium affects stem cells
- (2008) Ilaria Taddei et al. NATURE CELL BIOLOGY
- The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase
- (2008) Sachie Hiratsuka et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started